WST West Pharmaceutical Services Inc

Price (delayed)

$317.49

Market cap

$23.52B

P/E Ratio

34.58

Dividend/share

$0.71

EPS

$9.18

Enterprise value

$23.18B

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The net income has soared by 62% YoY and by 3.4% from the previous quarter
WST's EPS has surged by 60% year-on-year and by 3.3% since the previous quarter
West Pharmaceutical Services's quick ratio has decreased by 6% from the previous quarter
WST's debt is up by 3% year-on-year

Key stats

What are the main financial stats of WST
Market
Shares outstanding
74.08M
Market cap
$23.52B
Enterprise value
$23.18B
Valuations
Price to earnings (P/E)
34.58
Price to book (P/B)
10.14
Price to sales (P/S)
8.2
EV/EBIT
29.25
EV/EBITDA
25.32
EV/Sales
8.05
Earnings
Revenue
$2.88B
EBIT
$792.6M
EBITDA
$915.4M
Free cash flow
$382M
Per share
EPS
$9.18
Free cash flow per share
$5.13
Book value per share
$31.32
Revenue per share
$38.72
TBVPS
$42.53
Balance sheet
Total assets
$3.29B
Total liabilities
$968.5M
Debt
$331.2M
Equity
$2.33B
Working capital
$1.11B
Liquidity
Debt to equity
0.14
Current ratio
2.89
Quick ratio
1.99
Net debt/EBITDA
-0.37
Margins
EBITDA margin
31.8%
Gross margin
41.3%
Net margin
23.8%
Operating margin
26.5%
Efficiency
Return on assets
21.6%
Return on equity
30.8%
Return on invested capital
37.1%
Return on capital employed
29.2%
Return on sales
27.5%
Dividend
Dividend yield
0.22%
DPS
$0.71
Payout ratio
7.7%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
0.61%
1 week
5%
1 month
0.36%
1 year
-14.8%
YTD
-32.31%
QTD
5%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.88B
Gross profit
$1.19B
Operating income
$763.3M
Net income
$684.4M
Gross margin
41.3%
Net margin
23.8%
The net income has soared by 62% YoY and by 3.4% from the previous quarter
WST's operating income has soared by 53% YoY
The gross profit has grown by 36% YoY
WST's net margin is up by 31% year-on-year

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
P/E
34.58
P/B
10.14
P/S
8.2
EV/EBIT
29.25
EV/EBITDA
25.32
EV/Sales
8.05
WST's EPS has surged by 60% year-on-year and by 3.3% since the previous quarter
The stock's price to earnings (P/E) is 31% less than its last 4 quarters average of 50.0 and 29% less than its 5-year quarterly average of 48.6
WST's equity is up by 27% year-on-year
The price to book (P/B) is 27% lower than the last 4 quarters average of 13.8 but 15% higher than the 5-year quarterly average of 8.8
The P/S is 28% below the last 4 quarters average of 11.3 but 13% above the 5-year quarterly average of 7.2
West Pharmaceutical Services's revenue has increased by 24% YoY

Efficiency

How efficient is West Pharmaceutical Services business performance
The company's return on assets rose by 34% YoY
WST's return on invested capital is up by 32% year-on-year
West Pharmaceutical Services's ROE has increased by 28% YoY but it has decreased by 2.2% from the previous quarter
WST's return on sales is up by 24% year-on-year

Dividends

What is WST's dividend history
DPS
$0.71
Dividend yield
0.22%
Payout ratio
7.7%
Recent dividends

Financial health

How did West Pharmaceutical Services financials performed over time
WST's total assets is up by 20% year-on-year
West Pharmaceutical Services's quick ratio has decreased by 6% from the previous quarter
WST's debt is 86% smaller than its equity
WST's equity is up by 27% year-on-year
The debt to equity has contracted by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.